innoscripta SE Reports Strong H1 2026 Results, Confirms Full-Year Guidance

innoscripta SE (ISIN: DE000A40QVM8) announced its financial results for the first half of 2026, demonstrating robust growth and strategic progress. Revenue increased by 43% year-on-year to EUR 63.1 million, while adjusted EBIT rose by 49% to EUR 36.4 million, reflecting the company's successful execution of its expansion plans. The adjusted EBIT margin stood at 57.7%, underscoring operational efficiency.

The company attributed its strong performance to continued demand for its R&D tax allowance services, particularly in Germany, where the Forschungszulage remains a key growth driver. The number of customers surpassed 2,900 during the period, indicating sustained market adoption.

A significant development in the first half was the further enhancement of Clusterix, innoscripta's central platform infrastructure. The platform now offers automated data validation and improved data quality, enabling faster and more standardized processes. This technological advancement also supports consistent workflows across different markets, providing a solid foundation for international scaling.

International expansion progressed as planned, with successful market entries into France, the UK, and the US. In France, the company opened its first location near Toulouse and has already secured customers. The UK market entry was marked by a new office in Manchester, effective July 1, 2026. In the US, innoscripta has begun serving its first clients in this high-growth market, leveraging Clusterix's flexibility to adapt to various regulatory requirements.

These efforts align with the company's regional strategy, which also includes the opening of an office in Hamburg, Germany. The management board confirmed its guidance for the full year, expecting revenue of at least EUR 140 million and EBIT of at least EUR 80 million, assuming consistent timing of customer application submissions and approvals.

Detailed financial figures are available in the Half-Year Report on the company's website. Additionally, innoscripta will host a virtual earnings call today at 3:00 p.m. CEST to discuss the results, with dial-in details provided on its website.

The company's focus on innovation and internationalization positions it well for continued growth, as it capitalizes on the increasing demand for R&D management solutions worldwide. With a strong first half and confirmed guidance, innoscripta remains on track to achieve its strategic objectives for 2026.